
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5631012
[patent_doc_number] => 20060147481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Ketoprofen powder for oral use'
[patent_app_type] => utility
[patent_app_number] => 11/025943
[patent_app_country] => US
[patent_app_date] => 2005-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2153
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147481.pdf
[firstpage_image] =>[orig_patent_app_number] => 11025943
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/025943 | Ketoprofen powder for oral use | Jan 2, 2005 | Abandoned |
Array
(
[id] => 7040745
[patent_doc_number] => 20050159489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Treatment of diabetes with copper binding compounds'
[patent_app_type] => utility
[patent_app_number] => 11/023827
[patent_app_country] => US
[patent_app_date] => 2004-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9680
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159489.pdf
[firstpage_image] =>[orig_patent_app_number] => 11023827
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/023827 | Treatment of diabetes with copper binding compounds | Dec 27, 2004 | Issued |
Array
(
[id] => 6939804
[patent_doc_number] => 20050113367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 11/020624
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3788
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113367.pdf
[firstpage_image] =>[orig_patent_app_number] => 11020624
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/020624 | Pharmaceutical composition | Dec 22, 2004 | Abandoned |
Array
(
[id] => 6997469
[patent_doc_number] => 20050137247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Methods and compositions for treatment of hypertension'
[patent_app_type] => utility
[patent_app_number] => 11/020626
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16730
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137247.pdf
[firstpage_image] =>[orig_patent_app_number] => 11020626
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/020626 | Methods and compositions for treatment of hypertension | Dec 21, 2004 | Abandoned |
Array
(
[id] => 510240
[patent_doc_number] => 07199157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-03
[patent_title] => 'Use of treprostinil to improve kidney functions'
[patent_app_type] => utility
[patent_app_number] => 11/012722
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3673
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/199/07199157.pdf
[firstpage_image] =>[orig_patent_app_number] => 11012722
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/012722 | Use of treprostinil to improve kidney functions | Dec 15, 2004 | Issued |
Array
(
[id] => 9575398
[patent_doc_number] => 08765813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'Use of treprostinil to treat and prevent ischemic lesions'
[patent_app_type] => utility
[patent_app_number] => 11/012723
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6150
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11012723
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/012723 | Use of treprostinil to treat and prevent ischemic lesions | Dec 15, 2004 | Issued |
Array
(
[id] => 5913767
[patent_doc_number] => 20060128797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Method and composition for resuscitation'
[patent_app_type] => utility
[patent_app_number] => 11/013167
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7387
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128797.pdf
[firstpage_image] =>[orig_patent_app_number] => 11013167
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/013167 | Method and composition for resuscitation | Dec 14, 2004 | Abandoned |
Array
(
[id] => 5035443
[patent_doc_number] => 20070099982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Use of chp as an inhibitor of glutathione s-transferases and collagen IV'
[patent_app_type] => utility
[patent_app_number] => 10/596410
[patent_app_country] => US
[patent_app_date] => 2004-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3448
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099982.pdf
[firstpage_image] =>[orig_patent_app_number] => 10596410
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/596410 | Use of chp as an inhibitor of glutathione s-transferases and collagen IV | Dec 12, 2004 | Abandoned |
Array
(
[id] => 701894
[patent_doc_number] => 07064127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-20
[patent_title] => 'Treatment of hepatic fibrosis with imatinib mesylate'
[patent_app_type] => utility
[patent_app_number] => 11/002715
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3671
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/064/07064127.pdf
[firstpage_image] =>[orig_patent_app_number] => 11002715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/002715 | Treatment of hepatic fibrosis with imatinib mesylate | Dec 1, 2004 | Issued |
Array
(
[id] => 5904628
[patent_doc_number] => 20060046996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Method for treating hyperlipidemia'
[patent_app_type] => utility
[patent_app_number] => 10/997878
[patent_app_country] => US
[patent_app_date] => 2004-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2247
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20060046996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10997878
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/997878 | Method for treating hyperlipidemia | Nov 28, 2004 | Abandoned |
Array
(
[id] => 7255019
[patent_doc_number] => 20050075319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Method of treatment using bisphosphonic acid'
[patent_app_type] => utility
[patent_app_number] => 10/998849
[patent_app_country] => US
[patent_app_date] => 2004-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3120
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20050075319.pdf
[firstpage_image] =>[orig_patent_app_number] => 10998849
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/998849 | Method of treatment using bisphosphonic acid | Nov 28, 2004 | Issued |
Array
(
[id] => 6938641
[patent_doc_number] => 20050112204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Pharmaceutical formulations'
[patent_app_type] => utility
[patent_app_number] => 10/997022
[patent_app_country] => US
[patent_app_date] => 2004-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3605
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112204.pdf
[firstpage_image] =>[orig_patent_app_number] => 10997022
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/997022 | Pharmaceutical formulations | Nov 22, 2004 | Abandoned |
Array
(
[id] => 7117197
[patent_doc_number] => 20050070498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Enteral formulation'
[patent_app_type] => utility
[patent_app_number] => 10/992985
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4382
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10992985
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/992985 | Enteral formulation | Nov 18, 2004 | Issued |
Array
(
[id] => 7180752
[patent_doc_number] => 20050124593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Use of nitroxides in treating skin disease'
[patent_app_type] => utility
[patent_app_number] => 10/991822
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1604
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124593.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991822 | Use of nitroxides in treating skin disease | Nov 17, 2004 | Issued |
Array
(
[id] => 6939832
[patent_doc_number] => 20050113395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Method of treatment of atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 10/993052
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11016
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113395.pdf
[firstpage_image] =>[orig_patent_app_number] => 10993052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/993052 | Method of treatment of atherosclerosis | Nov 17, 2004 | Abandoned |
Array
(
[id] => 421929
[patent_doc_number] => 07273860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-25
[patent_title] => 'Method and pharmaceutical compositions for treating or inhibiting renal dysfunctions, diseases or disorders, particularly in diabetic patients'
[patent_app_type] => utility
[patent_app_number] => 10/988847
[patent_app_country] => US
[patent_app_date] => 2004-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6106
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/273/07273860.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988847 | Method and pharmaceutical compositions for treating or inhibiting renal dysfunctions, diseases or disorders, particularly in diabetic patients | Nov 15, 2004 | Issued |
Array
(
[id] => 6918744
[patent_doc_number] => 20050096305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Augmentation of antipsychotic agent pharmacotherapy with chromium picolinate supplementation'
[patent_app_type] => utility
[patent_app_number] => 10/983896
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5511
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096305.pdf
[firstpage_image] =>[orig_patent_app_number] => 10983896
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/983896 | Augmentation of atypical antipsychotic agent pharmacotherapy with chromium supplementation | Nov 8, 2004 | Issued |
Array
(
[id] => 6983867
[patent_doc_number] => 20050153937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Desensitization of compliment activation using monocyte/macrophage inhibitory compounds'
[patent_app_type] => utility
[patent_app_number] => 10/982449
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9210
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153937.pdf
[firstpage_image] =>[orig_patent_app_number] => 10982449
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/982449 | Desensitization of compliment activation using monocyte/macrophage inhibitory compounds | Nov 3, 2004 | Abandoned |
Array
(
[id] => 7098491
[patent_doc_number] => 20050130950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy'
[patent_app_type] => utility
[patent_app_number] => 10/981911
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8472
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130950.pdf
[firstpage_image] =>[orig_patent_app_number] => 10981911
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/981911 | Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy | Nov 3, 2004 | Abandoned |
Array
(
[id] => 5107703
[patent_doc_number] => 20070066581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/595589
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13495
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066581.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595589
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595589 | Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors | Oct 28, 2004 | Issued |